Advertisement

Related Videos

Opportunities to Optimize Cancer Policies Panel Discussion

Blase Polite, MD, MPP, FASCO, on Transforming the Drug Cost Curve in the United States: Not How But If

Daniel Goldstein, MD: Interventional Pharmacoeconomics - Why and How

Clifford A. Hudis, MD: Are Cancer Drug Prices in the U.S. the Problem or the Symptom?

Leonard B. Saltz, MD, on the Future of Interventional Pharmacoeconomics

Advertisement

Advertisement




Apr
11
Today In Oncology
Combined Tests Could Avoid Unnecessary Cystectomy, Study Finds
American Cancer Society Announces New Pediatric Adolescent and Young Adult Cancer Journal
Colorectal Cancer Duloxetine Not Effective in Preventing Oxaliplatin-Induced Peripheral Neuropathy
Advanced Prostate Cancer Radiographic Progression and PSA Increase in Patients Treated With Enzalutamide
CLL Linked to Increased Skin Cancer Risk and Mortality
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo